- Home
- MSC vs URGN Comparison
MSC vs URGN Comparison
Compare MSC & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- URGN
- Stock Information
- Founded
- MSC 2000
- URGN 2004
- Country
- MSC Hong Kong
- URGN United States
- Employees
- MSC N/A
- URGN N/A
- Industry
- MSC Hotels/Resorts
- URGN Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- URGN Health Care
- Exchange
- MSC Nasdaq
- URGN Nasdaq
- Market Cap
- MSC 924.4M
- URGN 896.3M
- IPO Year
- MSC 2018
- URGN 2017
- Fundamental
- Price
- MSC $4.61
- URGN $19.71
- Analyst Decision
- MSC
- URGN Strong Buy
- Analyst Count
- MSC 0
- URGN 8
- Target Price
- MSC N/A
- URGN $27.75
- AVG Volume (30 Days)
- MSC 3.1K
- URGN 1.3M
- Earning Date
- MSC 07-31-2025
- URGN 08-07-2025
- Dividend Yield
- MSC N/A
- URGN N/A
- EPS Growth
- MSC N/A
- URGN N/A
- EPS
- MSC N/A
- URGN N/A
- Revenue
- MSC $679,264,000.00
- URGN $94,238,000.00
- Revenue This Year
- MSC $8.92
- URGN $39.80
- Revenue Next Year
- MSC N/A
- URGN $108.94
- P/E Ratio
- MSC N/A
- URGN N/A
- Revenue Growth
- MSC 15.03
- URGN 10.85
- 52 Week Low
- MSC $2.30
- URGN $3.42
- 52 Week High
- MSC $9.30
- URGN $21.02
- Technical
- Relative Strength Index (RSI)
- MSC 51.26
- URGN 62.57
- Support Level
- MSC $4.48
- URGN $17.21
- Resistance Level
- MSC $5.04
- URGN $20.55
- Average True Range (ATR)
- MSC 0.40
- URGN 1.21
- MACD
- MSC -0.06
- URGN -0.18
- Stochastic Oscillator
- MSC 39.92
- URGN 66.92
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About URGN UroGen Pharma Ltd.
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.